Perinatal androgen exposure and adipose tissue programming: is there an impact on body weight fate? [0.03%]
围产期雄激素暴露与脂肪组织编程：对体重命运有影响吗？
Manuel Maliqueo,Bárbara Echiburú,Nicolás Crisosto
Manuel Maliqueo
Obesity is a major concern in public health because it is one of the main risk factors for the development of non-transmissible chronic diseases. The fact that there is a clear sex dimorphism in normal body fat distribution points out the r...
Bariatric surgery and diabetes remission: how far have we progressed? [0.03%]
肥胖症手术与糖尿病缓解：我们已经取得了多少进展？
Awadhesh Kumar Singh,Sunil Kumar Kota
Awadhesh Kumar Singh
Obesity and type 2 diabetes mellitus have been associated with higher morbidity and mortality. Bariatric surgery results in substantial and sustained weight loss in morbidly obese patients and improves obstructive sleep apnea. Furthermore, ...
Christina Anne Vinter,Ellen Nøhr
Christina Anne Vinter
Maternal obesity is recognized as one of the largest contributors to compromised health during pregnancy. Lifestyle interventions in obese pregnant women may be able to reduce gestational weight gain (GWG) but have shown limited success in ...
Vahab Fatourechi
Vahab Fatourechi
There has been an increase in the incidence of thyroid cancer in the last decade, mainly due to the increase in imaging. A majority of the cases are for papillary cancers
Corrigendum [0.03%]
勘误表
The neuropeptide Y-ergic system: potential therapeutic target against bone loss with obesity treatments [0.03%]
神经肽Y能系统：肥胖治疗中潜在的防治骨丢失靶点
Hamish A Fernando,Jessica Zibellini,Michelle Sh Hsu et al.
Hamish A Fernando et al.
Obesity is no longer considered to provide protection against osteoporosis. Moreover, treatments for obesity are now suspected of reducing bone mass. With the escalating incidence of obesity, combined with increases in the frequency, durati...
Improving diabetes diagnosis and management in myocardial infarction patients: overcoming clinical inertia [0.03%]
改善心肌梗死患者糖尿病的诊断和管理：克服临床惰性
Supriya Shore,Suzanne V Arnold,Thomas M Maddox
Supriya Shore
Diabetes is underdiagnosed and undertreated among acute myocardial infarction (AMI) patients. The early diagnosis and treatment of diabetes during AMI facilitates improved risk stratification, use of appropriate revascularization strategies...
Cardiovascular risk profiles in Type 2 diabetes and the impact of geographical setting [0.03%]
2型糖尿病的心血管风险谱系及其地理环境的影响
Jayne Smith-Palmer,Kristina S Boye,Magaly Perez-Nieves et al.
Jayne Smith-Palmer et al.
Cardiovascular (CV) disease is a leading morbidity and mortality in Type 2 diabetes (T2DM). Previous studies have shown geographic differences in the prevalence of CV and renal diseases. A literature review of longitudinal (≥5 years) studi...
Naiemh Abdalrahman,Suet Ching Chen,Jessie Ruijun Wang et al.
Naiemh Abdalrahman et al.
There are several mechanisms by which diabetes could affect bone mass and strength. These mechanisms include insulin deficiency; hyperglycemia; the accumulation of advanced glycation end products that may influence collagen characteristics;...
Colestilan for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis [0.03%]
氯司兰治疗透析慢性肾脏病患者高磷酸血症的研究
Francesco Locatelli,Nada Dimkovic,Goce Spasovski
Francesco Locatelli
Chronic kidney disease in the later stages poses many treatment challenges. Hyperphosphatemia is one that is well-known and is often linked to increased cardiovascular morbidity/mortality. Currently, a number of phosphate binders are availa...